Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

F038 - Dermoscopy: Learning From Easy and Difficult Cases

Friday, February 16; 3:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Recognize the different dermoscopy structures and criteria for melanocytic and non-melanocytic lesions
  • Analyze dermoscopic cases of different complexity (from easy to difficult cases)
  • Discuss the different approaches to arrive at correct diagnosis

Description

The purpose of this session is to increase knowledge in dermoscopy with the help of clinical cases. We will show cases of different complexity and sometimes the same type of lesion (melanocytic and non-melanocytic), emphasizing the presence of less common dermoscopic criteria in the most difficult case. Audience participation is very important.

Disclosures

  • Apalla, Zoe, MD: no financial relationships exist with commercial interests.
  • Cabo, Horacio Antonio, MD: no financial relationships exist with commercial interests.
  • Lallas, Aimilios, MD, MSc, PhD: 3Gen, LLC – A(EQ); Amgen – I(Fees); Avène – Speaker/Faculty Education(H); Bioderma – SP(H); Elsevier Inc. – O(Fees); Fotofinder – A(EQ); Galderma Laboratories, L.P. – SP(H); La Roche-Posay Laboratorie Pharmaceutique – I(Residency/Fellowship Program Funding), Speaker/Faculty Education(H); LEO Laboratories Ltd (LEO Pharma) – A(H), I(Grants/Research Funding); Novartis – A(H);
  • Longo, Caterina, MD, PhD: no financial relationships exist with commercial interests.
  • Marchiori Bakos, Renato, MD, PhD: no financial relationships exist with commercial interests.
  • Markowitz, Orit, MD: 3Gen, LLC – SP(H); Amgen – I(Grants/Research Funding); Caliber Imaging and Diagnostics Inc. – I(EQ); DUSA Pharmaceuticals, Inc – I(OB); Elsevier Inc. – Speaker/Faculty Education(H); Galderma Laboratories, L.P. – I(OB); Leo Pharma Inc – C(H), I(Grants/Research Funding); Lippincott Williams & Wilkins – O(Fees); Lucid, Inc. – I(EQ); MDSolarSciences Corporation – A(NC); MelaSciences – Speaker/Faculty Education(H); Michelson Diagnostics Ltd. – I(EQ); Novartis – I(Grants/Research Funding); Regeneron – C(H); Valeant Pharmaceuticals North America LLC – I(Grants/Research Funding);
  • Nathansohn, Nir, MD: no financial relationships exist with commercial interests.
  • Peralta, Maria Rosario, MD: no financial relationships exist with commercial interests.
  • Salerni, Gabriel Esteban, MD: no financial relationships exist with commercial interests.
  • Stolz, Wilhelm, MD: Almirall – SP(H); DermoScan – A(EQ); La Roche-Posay Laboratorie Pharmaceutique – SP(H); Leo Pharma Inc – SP(H); McGraw-Hill Companies – O(IP); Roche Laboratories – SP(H);
Event Details
  • Date
    Friday, February 16
  • Time
    3:30 PM - 5:30 PM
  • Location
    Ballroom 20A
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
  • Wilhelm Stolz, MD
  • Horacio Antonio Cabo, MD
Speakers
  • Aimilios Lallas, MD, MSc, PhD - Handout
  • Caterina Longo, MD, PhD
  • Gabriel Esteban Salerni, MD
  • Maria Rosario Peralta, MD
  • Nir Nathansohn, MD
  • Orit Markowitz, MD, FAAD
  • Renato Marchiori Bakos, MD, PhD
  • Zoe Apalla, MD